Ad
related to: lexapro interactions with drugs pdf handout example template printable full
Search results
Results From The WOW.Com Content Network
Lexapro is one of the most recognizable drug names of our modern era. Escitalopram, a less recognizable term, is the generic name for this common prescription antidepressant. ... For example, if ...
Lexapro on its own, at FDA-approved dosages, is unlikely to cause serotonin syndrome, but certain drug interactions can increase your serotonin levels and therefore, your risk of serotonin syndrome.
To avoid drug interactions, your healthcare provider will tell you which process to use and how to switch from one antidepressant to another safely based on your medications and overall health ...
Escitalopram, sold under the brand names Lexapro and Cipralex, among others, is an antidepressant medication of the selective serotonin reuptake inhibitor (SSRI) class. [9] It is mainly used to treat major depressive disorder , [ 9 ] generalized anxiety disorder , [ 9 ] panic disorder , obsessive-compulsive disorder , and social anxiety disorder .
Description - includes the proprietary name (if any), nonproprietary name, dosage form(s), qualitative and/or quantitative ingredient information, the pharmacologic or therapeutic class of the drug, chemical name and structural formula of the drug, and if appropriate, other important chemical or physical information, such as physical constants ...
This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification. Chemical/generic names are listed first, with brand names in parentheses.
Lexapro, which contains the active ingredient escitalopram, is an antidepressant that belongs to a class of drugs called selective serotonin reuptake inhibitors (SSRIs).
Most antidepressants, including SNRIs, are safe and effective in the geriatric population. The geriatric population is at greater risk for adverse effects relating to drug interaction as they are more likely to experience polypharmacy. [99] Decisions are often based on co-morbid conditions, drug interactions, and patient tolerance.